SCYNEXIS INC (SCYX) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 164 transactions totaling $18.0M, demonstrating a bullish sentiment with $8.6M in net insider flow. The most recent transaction on Oct 17, 2025 involved a transaction of 32,500 shares valued at $24.7K.
No significant insider buying has been recorded for SCYX in the recent period.
No significant insider selling has been recorded for SCYX in the recent period.
Based on recent SEC filings, insider sentiment for SCYX is bullish with an Insider Alignment Score of 74/100 and a net flow of $8.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at SCYNEXIS INC (SCYX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading SCYX stock, having executed 164 transactions in the past 90 days. The most active insider is Biopharma Partners II Lp Alta (Executive), who has made 14 transactions totaling $9.0M.
Get notified when executives and directors at SCYX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | David Angulo Gonzalez | Executive | Award | 32,500 | $0.76 | $24.7K | |
| Sep 12, 2024 | David Angulo Gonzalez | Executive | Purchase | 20,000 | $1.37 | $27.4K | |
| Jun 20, 2024 | Hanham Ann | Executive | Award | 23,000 | $N/A | $0 | |
| Jun 20, 2024 | Anido Armando | Executive | Award | 23,000 | $N/A | $0 | |
| Jun 20, 2024 | Philippe Tinmouth Brian | Executive | Award | 23,000 | $N/A | $0 | |
| Jun 20, 2024 | C. Gilman Steven | Executive | Award | 23,000 | $N/A | $0 | |
| Jun 20, 2024 | C. Hastings David | Executive | Award | 23,000 | $N/A | $0 | |
| Jun 20, 2024 | Macdonald Guy | Executive | Award | 23,000 | $N/A | $0 | |
| Feb 16, 2024 | Sukenick Scott | Executive | Payment | 15,179 | $1.63 | $24.7K | |
| Jan 26, 2024 | Sukenick Scott | Executive | Award | 143,675 | $N/A | $0 | |
| Jan 26, 2024 | Macleod Ivor | Executive | Award | 143,675 | $N/A | $0 | |
| Jan 26, 2024 | David Angulo Gonzalez | Executive | Award | 290,590 | $N/A | $0 | |
| Jun 15, 2023 | Macdonald Guy | Executive | Award | 10,000 | $N/A | $0 | |
| Jun 15, 2023 | C. Hastings David | Executive | Award | 10,000 | $N/A | $0 | |
| Jun 15, 2023 | Hanham Ann | Executive | Award | 10,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 68 | $13.3M | 73.1% |
Sale(S) | 4 | $4.7M | 25.8% |
Payment(F) | 7 | $124.5K | 0.7% |
Exercise (Options)(X) | 24 | $54.5K | 0.3% |
Award(A) | 34 | $24.7K | 0.1% |
Conversion(C) | 27 | $0 | 0.0% |
Insiders at SCYNEXIS INC are accumulating shares at an accelerated pace. With 24 insiders making 164 transactions totaling $13.3M in purchases versus $4.7M in sales, the net buying activity of $8.6M signals strong executive confidence. Biopharma Partners II Lp Alta (Executive) leads the buying activity with $9.0M in transactions across all time.